Lingbo Biotechnology (Hangzhou) Co., Ltd.
PrivateLast Round
Series A
Extension
Jun 12, 2024
Total Funding Raised
$13.8M
Company Overview
Lingbo Biotechnology (Hangzhou) Co., Ltd. is a biotechnology company that specializes in the research and development of tissue-engineered medical devices, particularly biologic artificial blood vessels.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lingbo Biotechnology (Hangzhou) Co., Ltd. Comparables
Compare Lingbo Biotechnology (Hangzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Humatrix Medical Technology (Suzhou) Co., Ltd. | 88% | |
| Jiangsu Baiyuda Life Technology Co., Ltd. | 87% | |
| Dialybrid S.r.l. | 84% |
For institutional investors. Book with your work email.
Lingbo Biotechnology (Hangzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 12, 2024 | ||||
| Series A | Nov 13, 2023 | ||||
| Pre Seed | Apr 24, 2021 | ||||
| Angel | Aug 24, 2020 |
For institutional investors. Book with your work email.
Lingbo Biotechnology (Hangzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGI Co-Win | Series A |
| Tasly Capital | Series A Extension |
| Panlin Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 12, 2024
Led by Tasly Capital.
- Nov 13, 2023
$14M round led by Panlin Capital.
For institutional investors. Book with your work email.
Lingbo Biotechnology (Hangzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lingbo Biotechnology (Hangzhou) Co., Ltd.'s valuation, stock price, and market status.
Is Lingbo Biotechnology (Hangzhou) Co., Ltd. a public or private company?
Lingbo Biotechnology (Hangzhou) Co., Ltd. is a private company.
What is the current stock price of Lingbo Biotechnology (Hangzhou) Co., Ltd.?
Lingbo Biotechnology (Hangzhou) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Lingbo Biotechnology (Hangzhou) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lingbo Biotechnology (Hangzhou) Co., Ltd. worth (valuation)?
Valuation information for Lingbo Biotechnology (Hangzhou) Co., Ltd. is not publicly available.
Can I buy Lingbo Biotechnology (Hangzhou) Co., Ltd. stock?
Lingbo Biotechnology (Hangzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lingbo Biotechnology (Hangzhou) Co., Ltd.'s last funding round?
Lingbo Biotechnology (Hangzhou) Co., Ltd.'s most recent funding round was Series A Extension on June 12, 2024.
Who are the main investors in Lingbo Biotechnology (Hangzhou) Co., Ltd.?
Key investors in Lingbo Biotechnology (Hangzhou) Co., Ltd. include Tasly Capital, Panlin Capital.
Will Lingbo Biotechnology (Hangzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for Lingbo Biotechnology (Hangzhou) Co., Ltd..
How can I track Lingbo Biotechnology (Hangzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Lingbo Biotechnology (Hangzhou) Co., Ltd.'s shares on secondary markets.